Please Wait

Applying Filters...

FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Articaine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

24 API Suppliers, 6 USDMF, 10 CEP/COS, 1 JDMF, 4 EU WC, 3 KDMF, 4 NDC API, 18 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

79 FDF Dossiers, 9 FDA Orange Book, 55 Europe, 12 Canada, 3 South Africa

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 4%; EQ 0.0085MG BASE/1.7ML (4%; EQ 0.005MG BASE/ML), INJECTABLE;INJECTION - 4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Kirsch Pharma, 2 Actylis

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 4 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 Regulatory FDF Prices

4 Regulatory FDF Prices

MARKET PLACE

6 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Exclusivities

1 US Exclusivities

REF. STANDARDS & IMPURITIES

3 EDQM, 10 Others

$ Xls

Filters

INJECTABLE;INJECTION - 4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG BASE/ML)

INJECTABLE;INJECTION - 4%; EQ 0.0085MG BASE/1.7ML (4%; EQ 0.005MG BASE/ML)

X

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Articaine Hydrochloride

Articaine Hydrochloride

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

24 API Suppliers

6 USDMF

10 CEP/COS

1 JDMF

4 EU WC

3 KDMF

4 NDC API

18 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

79 FDF Dossiers

9 FDA Orange Book

55 Europe

12 Canada

3 South Africa

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 4%; EQ 0.0085MG BASE/1.7ML (4%; EQ 0.005MG BASE/ML)

INJECTABLE;INJECTION - 4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Kirsch Pharma

2 Actylis

DIGITAL CONTENT

2 Data Compilation #PharmaFlow

4 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 Regulatory FDF Prices

MARKET PLACE

6 APIs

2 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Exclusivities

REF. STANDARDS & IMPURITIES

3 EDQM

10 Others

Filters